BenchSci
AI-powered platform for understanding disease biology and accelerating drug discovery.
About
BenchSci is building the world's first neuro-symbolic AI platform, ASCEND, to help scientists understand disease biology and accelerate drug discovery. ASCEND leverages a Biological Evidence Knowledge Graph (BEKG) and advanced AI to provide insights from diverse scientific data, including publications, multi-omics, and clinical trials. This platform aims to transform the drug discovery process by enabling R&D teams to go from hypothesis to successful experiment faster. Teams look it up for Biotech, Drug Discovery, AI-Driven Drug Discovery.
Frequently asked
What does BenchSci do?
BenchSci is a Biotech company that offers Platform. Teams look it up for Drug Discovery, AI-Driven Drug Discovery, Neuro-Symbolic AI. It is based in Toronto, Canada and was founded in 2015. Public records show about 274 people and $197M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has BenchSci raised?
BenchSci has raised a total of $197M in funding. The most recent round on record is Series D.
Where is BenchSci headquartered?
BenchSci is headquartered in Toronto, Canada.
When was BenchSci founded?
BenchSci was founded in 2015.
What industry does BenchSci operate in?
BenchSci operates in Biotech, Drug Discovery, AI-Driven Drug Discovery, Neuro-Symbolic AI, Biological Evidence Knowledge Graph.
How many employees does BenchSci have?
BenchSci has approximately 274 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.